$BON

Bon Natural Life Ltd

Bon Natural Life is a natural products and ingredients business operating in China through Xi’an App-Chem and its subsidiaries. It manufactures plant-extracted fragrance compounds for perfume and fragrance makers, natural health supplements such as powder drinks, and bioactive food ingredients used mainly as food additives and nutritional supplements. Its products and services serve customers in the functional food, personal care, cosmetics, natural medicine and pharmaceutical industries, as well as its own brands. Products include clary sage extracts, lavender oil, stachyose, milk thistle and apple extracts, and pomegranate extracts. Bon Natural Life also offers customized product development and formulation, product OEM, after-sale service and technical support. It makes money by supplying ingredients and finished products and providing these services to third-party customers and through its proprietary brands. Its mainland China headquarters is in Hangzhou.

No enriched coverage for $BON in the last 7 days.

No SEC Form 4 filings for $BON in the last 30 days.

See all $BON insider activity →
Med

Bon Natural Life Ltd (BON): Financial results for H1 2026

Bon Natural Life Ltd (BON) furnished an SEC Form 6-K — earnings release. Bon Natural Life Limited Announces Interim 2026 Results Bon Natural Life Limited (“we,” “us,” or “the Company”), a bio-ingredient solutions provider in the natural, health and personal care industries engaged in the research and development, manufacturing and sales of functional

Bon Natural Life announces $26M cooperation agreement with Beijing Huahai Keyuan

Bon Natural Life (BON) has announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a health products distributor in China. The agreement is for a term of 36 months and has a total contract value of $26 million. Under this agreement, Huahai Keyuan will distribute BON’s second-generation tea pigment-based digestive health products in Greater China.

BON sentiment & insider activity

Recent BON coverage spans financial news and earnings.

What's driving BON

  • Significant earnings deterioration suggests downward pressure on the stock.

    SEC EDGAR 6-K · Sep 23, 2026

  • Bon Natural Life's $26 million cooperation agreement with Beijing Huahai Keyuan indicates strategic expansion in China, potentially boosting sales and revenue.

    TipRanks · Nov 30, 2025

  • The announcement of a new product line and a significant cooperation agreement suggests potential positive momentum for BON's stock in the near term.

    Benzinga · Nov 25, 2025

  • The announcement of an $18 million cooperation agreement for innovative health products positions BON favorably within the bio-ingredient and health industry, potentially leading to increased revenue and market share.

    Benzinga · Sep 9, 2025

  • The announcement of a $16 million order signifies strong demand for BON's gut-health products, potentially boosting revenue and investor confidence.

    Benzinga · Jul 2, 2025

AlphAI scores every news story that mentions BON with an AI model for sentiment and relevance, and aggregates insider trades from Bon Natural Life Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BON

Score
$BONMedEarnings

Bon Natural Life Ltd (BON): Financial results for H1 2026

Bon Natural Life Ltd (BON) furnished an SEC Form 6-K — earnings release. Bon Natural Life Limited Announces Interim 2026 Results Bon Natural Life Limited (“we,” “us,” or “the Company”), a bio-ingredient solutions provider in the natural, health and personal care industries engaged in the research and development, manufacturing and sales of functional

Bon Natural Life announces $26M cooperation agreement with Beijing Huahai Keyuan

Bon Natural Life (BON) has announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a health products distributor in China. The agreement is for a term of 36 months and has a total contract value of $26 million. Under this agreement, Huahai Keyuan will distribute BON’s second-generation tea pigment-based digestive health products in Greater China.

Related tickers